KDR and cancer: Delta-like 4 (DLL4)-mediated Notch activation prevents excessive EC proliferation via downregulation of VEGFR-2 and VEGFR-3 function, which might serve as a novel cancer-favorable druggable target that might lack the CAEs of the other drugs of the current class [89,90].